We specialise in new approaches to prevent and treat dementia, and to improve care for people who have the condition.
Our people first approach is designed to make meaningful impact as swiftly as possible.
Dementia prevention, treatment and care research that puts people first
Around 54 million people worldwide have dementia, this is expected to rise to more than 152 million by 2050 (WHO), making it one of the world’s greatest health challenges.
"Dementia is the next global pandemic. We’re improving lives for people across the world, through innovative and cutting-edge research that spans prevention, treatment and care."
Professor Clive Ballard,
Professor of Age-Related Diseases
Pro-Vice Chancellor, University of Exeter Faculty of Health and Life Sciences
Improving lives for people living with dementia.
Together we are developing new drug therapies, new prevention approaches and better patient care.
Professor Clive Ballard
Professor of Age-Related Diseases and Pro-Vice Chancellor, University of Exeter Faculty of Health and Life Sciences
My main research specialisms are better treatments for neuropsychiatric symptoms in people with dementia, drug discovery, dementia prevention and improving mental health and quality of life for people with dementia in residential homes. I also have research interests in Lewy Body Dementia and Parkinson’s Disease Dementia. I advocate for better prescribing and treatment pathways to improve outcomes for individuals. I have led or co-authored well over 600 research papers and attracted grant income in excess of £150m over my research career, and won several awards including the Weston Brain Institute Outstanding Achievement Award.
Accelerating the search for new dementia treatment
Dementia risk could be reduced by 40 per cent, if meaningful action was taken across a range of different measures across the life course.